Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: Vaccine. 2009 May 27;27(32):4309–4319. doi: 10.1016/j.vaccine.2009.05.011

Table 4.

Deduced amino acid differences between each high virulence WEEV strain (TBT235 and McMillan) and both low virulence WEEV strains 71V-1658 and CO92-1356

Protein Amino acid positiona Low virulence phenotype High virulence phenotypeb

71V-1658 CO92 TBT235 McMillan
nsP1 59 Q Q Q E
467 K K K R
513 P P S P

nsP2 39 A A A E
433 T T I T
630 K K K N

nsP3c 56 R R K R
289 L L L P
332 P P P S
334 A A V T
365 L L F F
418 V V V D
447 K K K R
469 Y Y H H

nsP4 24 E E E D
27 L L L F
28 D D D E
147 A A A S
159 L L L I
537 P P S P
602 S S S N

capsid 57 S S S A
74 K K K E
250 R R W K
252 T T P T

E2 23 T T T A
69 F F F Y
146 H H H Q
157 H H H R
181 E E E K
214 R R R Q
224 K K K R
231 S S S L

6K 30 V V V I

E1 50 K K Q K
349 V V V T
374 S S S T
a

Amino acid position number corresponds to WEEV strain 71V-1658.

b

Boldface type specifies amino acid residues unique to the high virulence WEEV strains when compared to both low virulence WEEV strains.

c

There was an amino acid insertion of D at nsP3-167 in the McMillan strain and a deletion of V at nsP3-352 in the TBT235 strain.